V92-FC+™ is a viable allograft with an average of 1.5 million cells/cc of allograft packaged in a convenient syringe which thaws quickly and retains viability for four hours post thaw to accommodate clinical needs. The excellent handling characteristics of the allograft provide the surgeon with many opportunities of clinical placement, from packing and shaping to easy administration through a 6 mm bone funnel. The allograft provides the three key elements of bone formation. The foundation is an osteoconductive and osteoinductive bone scaffold composed of cancellous chips and demineralized cortical fibers to deliver a 100% human-derived product that mimics the structure of native bone. V92-FC+™ utilizes a novel cryoprotectant for preservation of the cell component that is DMSO-free, so there is no need to rinse or decant during the preparation of the product.